Literature DB >> 27604661

Clinical interaction between diabetes duration and aortic stiffness in type 2 diabetes mellitus.

D Agnoletti1,2, A S Mansour3, Y Zhang4, A D Protogerou5,6, S Ouerdane3, J Blacher2, M E Safar2.   

Abstract

Diabetes complications increase with disease duration. No study was performed on the relationship between aortic stiffness and diabetes duration, taking into account the respective influence of such factors on macro- and microcirculation. In total, 618 subjects with type 2 diabetes (259 men) attending the Department of Internal Medicine of Tizi Ouzou Hospital (Algeria) were studied in collaboration with Hotel-Dieu Hospital (Paris, France). Brachial blood pressure (BP), anthropometric, clinical and biological data were evaluated. Aortic stiffness was estimated by carotid-femoral pulse wave velocity (PWV). From lower to higher tertile of diabetes duration, age, BP and PWV (10.1±2.7 to 12.3±2.8 m s-1) increased, while diabetes control and renal function worsened (all P<0.01). Diabetes duration was independently associated with PWV (R2=0.035, P<0.0001), even after adjustment for age, BP, heart rate, cardiovascular events and metabolic syndrome. Diabetes duration was significantly correlated to the prevalence of microalbuminuria (OR (95% CL) 1.3 (1.06-1.63), P=0.01), independently of age, sex, BP and renal function. Increased aortic stiffness was independently associated with the prevalence of cardiovascular events (P<0.001), reaching its maximal value above the first 2 years of diabetes duration. In conclusion, diabetes duration is an independent determinant of aortic stiffness in subjects with type 2 diabetes, representing about 4% of PWV variability. Diabetes duration is associated with microvascular complications independently of renal function, and with macrovascular complications through the presence of increased aortic stiffness.

Entities:  

Mesh:

Year:  2016        PMID: 27604661     DOI: 10.1038/jhh.2016.58

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  27 in total

1.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes.

Authors:  Robert H Eckel; Momtaz Wassef; Alan Chait; Burton Sobel; Eugene Barrett; George King; Maria Lopes-Virella; Jane Reusch; Neil Ruderman; George Steiner; Helen Vlassara
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 3.  Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers.

Authors:  Massimo Volpe; Allegra Battistoni; Giuliano Tocci; Enrico Agabiti Rosei; Alberico L Catapano; Rosanna Coppo; Stefano del Prato; Sandro Gentile; Elmo Mannarino; Salvatore Novo; Domenico Prisco; Giuseppe Mancia
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

4.  Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies.

Authors:  R Asmar; A Benetos; J Topouchian; P Laurent; B Pannier; A M Brisac; R Target; B I Levy
Journal:  Hypertension       Date:  1995-09       Impact factor: 10.190

5.  Sex differences in the effect of diabetes duration on coronary heart disease mortality.

Authors:  Sundar Natarajan; Youlian Liao; Debajyoti Sinha; Guichan Cao; Daniel L McGee; Stuart R Lipsitz
Journal:  Arch Intern Med       Date:  2005-02-28

6.  Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?

Authors:  Kennedy Cruickshank; Lisa Riste; Simon G Anderson; John S Wright; Graham Dunn; Ray G Gosling
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

7.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

8.  Diabetes mellitus and renal failure: effects on large artery stiffness.

Authors:  S Aoun; J Blacher; M E Safar; J J Mourad
Journal:  J Hum Hypertens       Date:  2001-10       Impact factor: 3.012

Review 9.  Arterial stiffness, pulse pressure, and the kidney.

Authors:  Michel E Safar; Gérard E Plante; Albert Mimran
Journal:  Am J Hypertens       Date:  2014-12-04       Impact factor: 2.689

10.  Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study.

Authors:  R Paul Wadwa; Elaine M Urbina; Andrea M Anderson; Richard F Hamman; Lawrence M Dolan; Beatriz L Rodriguez; Stephen R Daniels; Dana Dabelea
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 19.112

View more
  15 in total

1.  Central-to-brachial blood pressure amplification in type 2 diabetes: a systematic review and meta-analysis.

Authors:  Rachel E Climie; Martin G Schultz; James W Fell; Lorena Romero; Petr Otahal; James E Sharman
Journal:  J Hum Hypertens       Date:  2018-11-13       Impact factor: 3.012

2.  Association between serum indoxyl sulfate levels with carotid-femoral pulse wave velocity in patients with chronic kidney disease.

Authors:  Sheng-Chao Wang; Yu-Hsien Lai; Chin-Hung Liu; Chih-Hsien Wang; Bang-Gee Hsu; Jen-Pi Tsai
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

3.  Serum resistin as an independent marker of aortic stiffness in patients with coronary artery disease.

Authors:  Ji-Hung Wang; Chung-Jen Lee; Chiu-Fen Yang; Yu-Chih Chen; Bang-Gee Hsu
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

4.  Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients.

Authors:  Jia-Sian Hou; Chih-Hsien Wang; Yu-Hsien Lai; Chiu-Huang Kuo; Yu-Li Lin; Bang-Gee Hsu; Jen-Pi Tsai
Journal:  Nutrients       Date:  2020-07-21       Impact factor: 5.717

5.  Metabolic Syndrome With Aortic Arterial Stiffness And First Hospitalization Or Mortality In Coronary Artery Disease Patients.

Authors:  Yen-Chih Chen; Bang-Gee Hsu; Ji-Hung Wang; Chung-Jen Lee; Jen-Pi Tsai
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-08       Impact factor: 3.168

6.  Serum P-Cresyl Sulfate Is a Predictor of Central Arterial Stiffness in Patients on Maintenance Hemodialysis.

Authors:  Yu-Hsien Lai; Chih-Hsien Wang; Chiu-Huang Kuo; Yu-Li Lin; Jen-Pi Tsai; Bang-Gee Hsu
Journal:  Toxins (Basel)       Date:  2019-12-21       Impact factor: 4.546

Review 7.  Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors.

Authors:  Dimitrios Patoulias; Christodoulos Papadopoulos; Konstantinos Stavropoulos; Ioanna Zografou; Michael Doumas; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-14       Impact factor: 3.738

8.  Prognostic significance of the renal resistive index in the primary prevention of type II diabetes.

Authors:  Pascal Delsart; Anne Vambergue; Sandro Ninni; François Machuron; Bénédicte Lelievre; Guillaume Ledieu; Pierre Fontaine; Emilie Merlen; Marie Frimat; François Glowacki; David Montaigne; Claire Mounier-Vehier
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-31       Impact factor: 3.738

9.  Associations between Type 2 Diabetes Mellitus and Arterial Stiffness: A Prospective Analysis Based on the Maine-Syracuse Study.

Authors:  Merrill F Elias; Georgina E Crichton; Peter J Dearborn; Michael A Robbins; Walter P Abhayaratna
Journal:  Pulse (Basel)       Date:  2017-08-26

10.  Cross-Sectional Relationship between Carotid-Femoral Pulse Wave Velocity and Biomarkers in Vascular-Related Diseases.

Authors:  Jinbo Liu; Kuanting Wang; Huan Liu; Hongwei Zhao; Wei Huang; Na Zhao; Lihong Li; Hongyu Wang
Journal:  Int J Hypertens       Date:  2020-05-23       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.